Skip to main content

Table 3 MICs (μg/ml) of quinolones for different colonies of E coli KZM120 containing each of the plasmids pBS3.8, pBS3.25 and pBS3.13

From: Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants

Plasmids

Antibiotics

 

NAL

NOR

SPA

CIP

ENX

LEV

GAR

GRP

TRV

MOX

pGEM-T

1

0.016

0.032

0.002

0.032

0.004

0.002

0.001

0.004

0.004

pBS3.8 1

1

0.032

0.032

0.008

0.064

0.016

0.032

0.008

0.032

0.016

pBS3.8 2

1

0.016

0.032

0.004

0.064

0.008

0.016

0.008

0.032

0.016

pBS3.8 3

1

0.016

0.032

0.004

0.064

0.008

0.016

0.008

0.032

0.016

pBS3.13 1

1

0.016

0.032

0.004

0.064

0.008

0.008

0.004

0.016

0.016

pBS3.13 2

1

0.016

0.032

0.004

0.064

0.008

0.002

0.002

0.008

0.008

pBS3.13 3

1

0.016

0.032

0.004

0.064

0.008

0.002

0.002

0.008

0.008

pBS3.25 1

1

0.016

0.032

0.004

0.064

0.008

0.064

0.016

0.032

0.032

pBS3.25 2

1

0.016

0.032

0.004

0.064

0.008

0.008

0.004

0.016

0.008

pBS3.25 3

1

0.016

0.032

0.004

0.064

0.008

0.008

0.004

0.016

0.008

  1. Three colonies were tested for each plasmid.
  2. NAL; nalidixic acid, NOR; norfloxacin, SPA; sparfloxacin, CIP; ciprofloxacin, ENX; enoxacin, LEV; levofloxacin, GAR; garenoxacin, GRP; grepafloxacin, TRV; trovafloxacin, MOX; moxifloxacin.